| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8221925 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 6 Pages |
Abstract
An adaptive boost strategy is feasible, with an acceptable grade 3 gastrointestinal toxicity rate and a very encouraging tumor response rate. The results suggest that there should still be room for further dose escalation of the residual tumor with the aim of increasing pathologic complete response and/or cCR rates.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Paolo MD, Claudio PyD, Najla MD, Monica MD, Vincenzo MD, Saverio MD, Paola MD, Elena MD, Andrea MD, Francesco MD, Claudio MD, Nicola A. MD, Sara PyD, Carlo MD, Riccardo PhD, Nadia MD,